DWTX insider filings

Dogwood Therapeutics, Inc. — 27 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-27. Screen DWTX transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Sealbond Ltd — Director, 10% owner & Conjoint Inc. — Director, 10% owner & CK Life Sciences Intl (Holdings) Inc — Director, 10% owner1——1

Recent insider filings — Dogwood Therapeutics, Inc.

FiledFormInsiderReported transactionsSource
2026-10-274Sealbond Ltd — Director, 10% owner
Conjoint Inc. — Director, 10% owner
CK Life Sciences Intl (Holdings) Inc — Director, 10% owner
Grant/award (A): 4,098,360 @ $1.22EDGAR
2026-06-174Keefer David R — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2026-06-174De La Rosa Abel — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2026-06-174Whitley Richard James — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2026-06-174Thomas John C — DirectorGrant/award (A): 16,800 (derivative) @ $0EDGAR
2026-03-064Duncan Gregory Scott — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 330,000 (derivative) @ $0EDGAR
2026-03-064Gendreau Roger Michael — CHIEF MEDICAL OFFICERGrant/award (A): 82,500 (derivative) @ $0EDGAR
2026-03-064Grosswald Ralph — SVP OF OPERATIONSGrant/award (A): 82,500 (derivative) @ $0EDGAR
2026-03-064Walsh Angela — Chief Financial OfficerGrant/award (A): 82,500 (derivative) @ $0EDGAR
2025-12-054Duncan Gregory Scott — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 460,000 (derivative) @ $0EDGAR
2025-12-054Gendreau Roger Michael — CHIEF MEDICAL OFFICERGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-12-054Grosswald Ralph — SVP OF OPERATIONSGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-12-054Walsh Angela — Chief Financial OfficerGrant/award (A): 150,000 (derivative) @ $0EDGAR
2025-11-254Sealbond Ltd — Director, 10% owner
Conjoint Inc. — Director, 10% owner
CK Life Sciences Intl (Holdings) Inc — Director, 10% owner
Conversion (C): 21,610,950 · Conversion (C): 2,842,638 · Conversion (C): 2,161.09 (derivative) @ $0 · Conversion (C): 284.26 (derivative) @ $0EDGAR
2025-07-014Gendreau Roger Michael — CHIEF MEDICAL OFFICERGrant/award (A): 12,075 (derivative) @ $0EDGAR
2025-07-014Grosswald Ralph — SVP OF OPERATIONSGrant/award (A): 12,075 (derivative) @ $0EDGAR
2025-07-014Duncan Gregory Scott — CHIEF EXECUTIVE OFFICER, DirectorGrant/award (A): 40,000 (derivative) @ $0EDGAR
2025-07-014Keefer David R — DirectorGrant/award (A): 2,362 (derivative) @ $0EDGAR
2025-07-014Walsh Angela — Chief Financial OfficerGrant/award (A): 12,075 (derivative) @ $0EDGAR
2025-07-014De La Rosa Abel — DirectorGrant/award (A): 2,362 (derivative) @ $0EDGAR
2025-07-014Whitley Richard James — DirectorGrant/award (A): 2,362 (derivative) @ $0EDGAR
2025-07-014Thomas John C — DirectorGrant/award (A): 2,362 (derivative) @ $0EDGAR
2025-06-234Keefer David R — DirectorGrant/award (A): 210 (derivative) @ $0 · Grant/award (A): 210 (derivative) @ $0EDGAR
2025-06-234De La Rosa Abel — DirectorGrant/award (A): 210 (derivative) @ $0 · Grant/award (A): 210 (derivative) @ $0EDGAR
2025-06-234Whitley Richard James — DirectorGrant/award (A): 210 (derivative) @ $0 · Grant/award (A): 210 (derivative) @ $0EDGAR
2025-06-234Thomas John C — DirectorGrant/award (A): 210 (derivative) @ $0 · Grant/award (A): 210 (derivative) @ $0EDGAR
2025-03-174CK Life Sciences Intl (Holdings) Inc — Director, 10% ownerGrant/award (A): 284.26 (derivative) @ $7.01EDGAR

Recent 8-K events — Dogwood Therapeutics, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-198-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-178-K5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-268-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-188-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-128-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-208-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-01-138-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=DWTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs